These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25089549)

  • 1. Antitumor necrosis factor α is more effective than conventional medical therapy for the prevention of postoperative recurrence of Crohn's disease: a meta-analysis.
    Nguyen DL; Solaimani P; Nguyen ET; Jamal MM; Bechtold ML
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1152-9. PubMed ID: 25089549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
    Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
    Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis.
    Singh S; Garg SK; Pardi DS; Wang Z; Murad MH; Loftus EV
    Gastroenterology; 2015 Jan; 148(1):64-76.e2; quiz e14. PubMed ID: 25263803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.
    Carla-Moreau A; Paul S; Roblin X; Genin C; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Mar; 47(3):191-6. PubMed ID: 25488057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.
    Tursi A; Elisei W; Principi M; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E; Brandimarte G
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):261-5. PubMed ID: 25267953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence.
    Qiu Y; Mao R; Chen BL; He Y; Zeng ZR; Chen MH
    J Crohns Colitis; 2015 Oct; 9(10):918-27. PubMed ID: 26116553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for Crohn's disease and anti-TNF agents: the changing scenario.
    Sorrentino D; Fogel S; Van den Bogaerde J
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):689-700. PubMed ID: 24161133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis.
    Uchino M; Ikeuchi H; Hata K; Minagawa T; Horio Y; Kuwahara R; Nakamura S; Watanabe K; Saruta M; Fujii T; Kobayashi T; Sugimoto K; Hirai F; Esaki M; Hiraoka S; Matsuoka K; Shinzaki S; Matsuura M; Inoue N; Nakase H; Watanabe M
    J Gastroenterol Hepatol; 2021 Apr; 36(4):864-872. PubMed ID: 33002235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
    Sands BE; Feagan BG; Rutgeerts P; Colombel JF; Sandborn WJ; Sy R; D'Haens G; Ben-Horin S; Xu J; Rosario M; Fox I; Parikh A; Milch C; Hanauer S
    Gastroenterology; 2014 Sep; 147(3):618-627.e3. PubMed ID: 24859203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis.
    Erős A; Farkas N; Hegyi P; Szabó A; Balaskó M; Veres G; Czakó L; Bajor J; Alizadeh H; Rakonczay Z; Mikó A; Habon T; Erőss B; Bérczi B; Sarlós P
    Dig Liver Dis; 2019 Aug; 51(8):1086-1095. PubMed ID: 31278016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα.
    Kiss LS; Lovasz BD; Golovics PA; Vegh Z; Farkas K; Molnar T; Palatka K; Papp M; Mohas A; Szilagyi BK; Fekete SA; Mandel M; Lakatos PL
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):135-40. PubMed ID: 23799211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.
    Gibson DJ; Murphy DJ; Smyth AE; McEvoy SH; Keegan D; Byrne K; Mulcahy HE; Cullen G; Malone DE; Doherty GA
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):956-62. PubMed ID: 26049706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T; Watanabe T
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence.
    Collins M; Sarter H; Gower-Rousseau C; Koriche D; Libier L; Nachury M; Cortot A; Zerbib P; Blanc P; Desreumaux P; Colombel JF; Peyrin-Biroulet L; Pineton de Chambrun G
    J Crohns Colitis; 2017 Mar; 11(3):281-288. PubMed ID: 27578800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of postoperative recurrence of Crohn's disease.
    van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
    J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network meta-analysis on the efficacy of 5-aminosalicylates, immunomodulators and biologics for the prevention of postoperative recurrence in Crohn's disease.
    Yang Z; Ye X; Wu Q; Wu K; Fan D
    Int J Surg; 2014; 12(5):516-22. PubMed ID: 24576593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.
    Burr NE; Hall B; Hamlin PJ; Selinger CP; Ford AC; O'Connor A
    J Crohns Colitis; 2019 May; 13(6):693-701. PubMed ID: 30561586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics for the prevention of postoperative Crohn's disease recurrence: A systematic review and meta-analysis.
    Zhao Y; Ma T; Chen YF; He XY; Ren LH; Chen J; Fang L; Su JW; Zhang HJ; Shi RH
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):637-49. PubMed ID: 25958300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center.
    Nobile S; Gionchetti P; Rizzello F; Calabrese C; Campieri M
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):458-65. PubMed ID: 24445727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.